Aandeel 1786 SCIVISION BIOTECH INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen SciVision Biotech Inc.

Aandelen

1786

TW0001786002

slotkoers Taiwan S.E.
Andere beurzen
 00:00:00 10-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
98,6 TWD -3,33% Intraday-grafiek van SciVision Biotech Inc. -7,85% +27,06%
10/04 De producten Flexotron Solo (2,2%) en Flexotron Magnum (3%) van SciVision Biotech Inc. verkrijgen licenties voor medische hulpmiddelen CI
09/04 CREATEFILL van Scivision Biotech Inc. verkrijgt de Medical Device License van klasse III medische hulpmiddelen CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses
Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices
SciVision Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
SciVision Biotech Inc.(TWSE:1786) added to S&P Global BMI Index
SciVision Biotech Inc.'s Product, Cross-Linked Hyaluronic Acid Synovial Fluid Supplement ?Hyajoint Plus? Obtains Medical Device License
SciVision Biotech Inc. Announces Corporate Governance Officer Changes
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
SciVision Biotech Inc. Approves Cash Dividend, Payable on August 18, 2023
SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
SciVision Biotech Inc.(TWSE:1786) dropped from S&P Global BMI Index
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
SciVision Biotech : Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.
SciVision Biotech : Announce the record date for cash dividend
SciVision Biotech : Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders
SciVision Biotech Inc. Announces Cash Dividend, Payable on August 18, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 1786
  4. Nieuws SciVision Biotech Inc.
  5. Andere talen